Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues
Authors:
- G.S. BesraGBG.S. Besra
- M.R. McNeilMMM.R. McNeil
- 1 January 1998
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 78 (2) , 123-131
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- WHO issues another gloomy tuberculosis reportNature Medicine, 1996
- PROSPECTS FOR NEW INTERVENTIONS IN THE TREATMENT AND PREVENTION OF MYCOBACTERIAL DISEASEAnnual Review of Microbiology, 1995
- Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene clusterJournal of Bacteriology, 1994
- The Third Epidemic—Multidrug-Resistant TuberculosisChest, 1994
- The Emergence of Drug-Resistant Tuberculosis in New York CityNew England Journal of Medicine, 1993
- Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurumAntimicrobial Agents and Chemotherapy, 1991
- Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 1989
- Biosynthesis of Bacterial Polysaccharide Chains Composed of Repeating Units1987
- The biosynthesis of galactofuranosyl residues in galactocaroloseBiochemical Journal, 1971
- Uridine diphosphate α-d-galactofuranose, an intermediate in the biosynthesis of galactofuranosyl residuesBiochemical Journal, 1970